STTK

Shattuck Labs, Inc. - Common Stock (STTK)

About Shattuck Labs, Inc. - Common Stock (STTK)

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Details

Daily high

$6.21

Daily low

$5.86

Price at open

$6.09

52 Week High

$8.33

52 Week Low

$1.70

Market cap

603.2M

Dividend yield

Volume

1.0M

Avg. volume

1.2M

P/E ratio

-11.81

Shattuck Labs, Inc. - Common Stock News